Global Biopharmaceuticals Market Report 2020 Market Size Trends and Forecast

Global Biopharmaceuticals Market 2020-2026

1

Transilience Market Research | Sales@transiliencemarketresearch.com

Global Biopharmaceuticals

Market 2020 By Product [Monoclonal antibody, Interferon,

Insulin,Growth and coagulation factor, Erythropoietin, Vaccine and others],By Application [Oncology,

Blood

disorder,Metabolic

disease,Infectious

disease,Cardiovascular

disease,Neurological disease, Immunology and others]: Global Forecast to 2026 and COVID-19 Impact Outlook Global Biopharmaceuticals Market is valued at USD 244.51 Billion (€ 206.13 Bn) in 2019 and expected to reach USD 599.92 Billion (€ 505.73 Bn) by 2026 with the CAGR of 13.68 % over the forecast period.

Scope of the report Biopharmaceuticals are drugs synthesized from biological sources. Biopharmaceuticals have several clinical applications in disease diagnosis, therapy and prevention. Biopharmaceuticals helps to cure or treat diseases such as cancer, diabetes, heart disease, Alzheimer’s and hepatitis C. Worldwide the use of biopharmaceuticals has grown in the last few years. Biopharmaceuticals generate revenues of nearly USD 150 Billion worldwide making up about 20 % of the pharma market. Biopharmaceuticals is by far the fastest growing part of pharma industry and is expected to witness significant growth in forecast period.

KNOW MORE This report analyses the global market for Biopharmaceuticals. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.

Key Players 1. Sanofi,Pfizer Inc. 2. Novo Nordisk A/S 3. Merck & Co. Inc. 2

4. Johnson & Johnson 5. F. Hoffmann-La Roche Ltd. 6. Eli Lilly and Company Transilience Market Research | Sales@transiliencemarketresearch.com

7. Biogen Inc. 8. Abbott Laboratories Amgen Inc 9. others Above mentioned companies were scrutinized to assess competitive landscape of global Biopharmaceuticals market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.

Review period: (2016-2026) Historic Period: 2016 to 2019 Forecast Period: 2020 to 2026 Base Year: 2019 Unit: USD Billion This Biopharmaceuticals market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.

REQUEST SAMPLE

Regions 

North America: U.S., Canada and Rest of North America



Europe: UK, France, Germany, Italy, Spain and Rest of Europe



Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific



Latin America: Brazil, Mexico, Argentina and Rest of Latin America



Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa

Global Biopharmaceuticals Market Dynamics Global Biopharmaceuticals Market is driven by prevalence of chronic diseases, geriatric population, rising Research and development investments in the industry. Worldwide cancer prevalence is Transilience Market Research | Sales@transiliencemarketresearch.com

3

estimated to have risen to 18.1 million new cases causing nearly 9.6 million deaths in 2018. As per research 1 in 5 men and 1 in 6 women worldwide develop cancer and 1 in 8 men and 1 in 11 women die from the disease. According to International Agency for Research on Cancer By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Further growing Investments in R&D is expected to drive market growth in forecast period. For instance in May 2020 three pharmaceutical giants Novartis, Pfizer and the Merck group have backed Swiss company FoRx which is into cancer therapeutics. Industry is witnessing rise in capital investments in small firms and significant collaborations to offer better pharmaceutical products to consumers driving the market growth. MPM Capital Announced $100M Oncology Innovations Fund as Part of Novel Venture Philanthropy Collaboration with Dana-Farber Cancer Institute. However, stringent regulatory policies for drug approvals and longer clinical trials are hindering the growth of market. The rise in advancements drug discovery and development process, untapped markets, will offer significant opportunities to the major market stakeholders.

Regional Insights North America dominates the global Biopharmaceuticals market. The growth in the region was attributed to the factors such as presence of key players, heavy capital investments of research and development for new drug development and discovery and prevalence of chronic diseases. The United States accounts major share of global biopharmaceuticals market. The country leads in biopharmaceuticals R&D and is expected to witness significant growth in future. According to the Pharmaceutical Research and Manufacturers Association firms in United States conduct 50 per cent of world's R&D in pharmaceuticals industry and launch key Biopharmaceuticals products in the market holding maximum number of intellectual property rights on most of the new medicines.

Europe was second in terms of revenue generation followed by Asia Pacific. Europe has world-class research institutions, medical centres and hospitals that provide a strong basis for sourcing and developing scientific and clinical innovations. From 2012 to 2018, available venture capital in healthcare sector has tripled, to USD 2.3 billion. Asia Pacific is the fastest growing region and is expected to grow at significant pace thanks to expanding healthcare industry, rise in capital investments and rising burden of chronic diseases.

Market Segmentation 

Product o Monoclonal antibody o Interferon o Insulin Transilience Market Research | Sales@transiliencemarketresearch.com

4



o Growth and coagulation factor o Erythropoietin o Vaccine Application o Oncology o Blood disorder o Metabolic disease o Infectious disease o Cardiovascular disease o Neurological disease o Immunology o Others

Report Coverage 

An overview of the global Biopharmaceuticals market



In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market



Global Biopharmaceuticals

market revenue data historic and forecast analysis

(2016 to 2026) 

Characterization

and

quantification

of

the

market

segments

for

Biopharmaceuticals market 

Market share analysis of key market participants and their competitive landscape

Important Questions Answered by Global Biopharmaceuticals Market Report 

What is the impact of COVID 19 epidemic on the global Biopharmaceuticals market?



Which is mostly affected region, country?



Which is the current largest and fastest-growing region?



What is the market size and growth rate of the global Biopharmaceuticals market?



What are current factors affecting the growth of market?



What are Key trends and opportunity areas?



Within Biopharmaceuticals market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?



What are the major strategies adopted by leading market companies?



What are company challenges and essential success factors by market segment?



How company offerings and supply chain capabilities are shifting to meet emerging market needs?

Transilience Market Research | Sales@transiliencemarketresearch.com

5

This report highlights the impact of the Covid-19 pandemic on Global Biopharmaceuticals Market.

By combining data from a range of industry sources, as well as predictive modelling and market trend analysis, we provide an evidence-based set of projections that will allow organisations to plan their strategies more effectively. The report gives in depth analysis of short term and long term impacts of epidemic on the industry.

The COVID 19 impact assessment of Global Biopharmaceuticals Market is divided into following sections: Section1: Pre Lockdown This part of the report looks at how market changed throughout early 2020, as the spread of COVID19 intensified on different geographies.

Section2: During Lockdown This part of the report collects data from across the sector to know how people have responded to lockdown. It analyses the impact of the epidemic on the workforce in the industry and disruption in various regions and countries Section3: Post Lockdown This part of the report project what sector recovery could look like and summarises ways in which the business landscape could shift.

Get detailed COVID 19 Impact Analysis on Global Biopharmaceuticals Market Here

6

Transilience Market Research | Sales@transiliencemarketresearch.com

TABLE OF CONTENTS 1. Introduction 1.1. Report Description 1.2. Market Segmentation 1.3. Research Methodology 1.4. List of Abbreviations 2. Executive Summary 3. Market Overview 3.1. Market Definition 3.2. Market Scope 3.3. Market Drivers 3.4. Market Restraints 3.5. Market Opportunities and Trends 3.6. Porter’s five force analysis 3.7. SWOT Analysis 3.8. PEST Analysis 3.9. Patent Analysis 3.10.

Impact of COVID 19 on Global Biopharmaceuticals Market

4. Biopharmaceuticals Market, By Product, Market Size, Consumption and Forecast 2016 -2026 (USD Billion) 4.1. Global Biopharmaceuticals Market By Product, 2016 -2026 (USD Billion) 4.1.1.Global Biopharmaceuticals Market By Monoclonal antibody 4.1.2.Global Biopharmaceuticals Market By Interferon 4.1.3.Global Biopharmaceuticals Market By Insulin 4.1.4.Global Biopharmaceuticals Market By Growth and coagulation factor 4.1.5.Global Biopharmaceuticals Market By Erythropoietin 4.1.6.Global Biopharmaceuticals Market By Vaccine 4.1.7.Global Biopharmaceuticals Market By Immunology 4.1.8.Global Biopharmaceuticals Market By Others 4.2. Global Biopharmaceuticals Market By Product Share, 2016 -2026 (%) 5. Biopharmaceuticals Market, By Application, Market Size, Consumption and Forecast 2016 7

2026 (USD Billion) 5.1. Global Biopharmaceuticals Market By Application, 2016 -2026 (USD Billion) 5.1.1.Global Biopharmaceuticals Market By Oncology Transilience Market Research | Sales@transiliencemarketresearch.com

5.1.2.Global Biopharmaceuticals Market By Blood disorder 5.1.3.Global Biopharmaceuticals Market By Metabolic disease 5.1.4.Global Biopharmaceuticals Market By Infectious disease 5.1.5.Global Biopharmaceuticals Market By Cardiovascular disease 5.1.6.Global Biopharmaceuticals Market By Neurological disease 5.2. Global Biopharmaceuticals Market By Application Share, 2016 -2026 (%) 6. Biopharmaceuticals Market, By Region Market Size, Consumption and Forecast 2016 -2026 6.1. NORTH AMERICA 6.1.1.Key Findings 6.1.2.Impact of COVID 19 6.1.3.Key market trends, growth factors and opportunities 6.1.4.North America Biopharmaceuticals Market by Country 2016 -2026 (USD Billion) 6.1.5.North America Biopharmaceuticals Market By Product 2016 -2026 (USD Billion) 6.1.6.North America Biopharmaceuticals Market By Application 2016 -2026 (USD Billion) 6.2. EUROPE 6.2.1.Key Findings 6.2.2.Impact of COVID 19 6.2.3.Key market trends, growth factors and opportunities 6.2.4.Europe Biopharmaceuticals Market by Country 2016 -2026 (USD Billion) 6.2.5.Europe Biopharmaceuticals Market By Product 2016 -2026 (USD Billion) 6.2.6.Europe Biopharmaceuticals Market By Application 2016 -2026 (USD Billion) 6.3. ASIA PACIFIC 6.3.1.Key Findings 6.3.2.Impact of COVID 19 6.3.3.Key market trends, growth factors and opportunities 6.3.4.Asia Pacific Biopharmaceuticals Market by Country 2016 -2026 (USD Billion) 6.3.5.Asia Pacific Biopharmaceuticals Market By Product 2016 -2026 (USD Billion) 6.3.6.Asia Pacific Biopharmaceuticals Market By Application 2016 -2026 (USD Billion) 6.4. LATIN AMERICA 6.4.1.Key Findings 6.4.2.Impact of COVID 19 6.4.3.Key market trends, growth factors and opportunities 6.4.4.Latin America Biopharmaceuticals Market by Country 2016 -2026 (USD Billion) 6.4.5.Latin America Biopharmaceuticals Market By Product 2016 -2026 (USD Billion)

Transilience Market Research | Sales@transiliencemarketresearch.com

8

6.4.6.Latin America Biopharmaceuticals Market By Application 2016 -2026 (USD Billion) 6.5. MIDDLE EAST AND AFRICA 6.5.1.Key Findings 6.5.2.Impact of COVID 19 6.5.3.Key market trends, growth factors and opportunities 6.5.4.Middle East and Africa Biopharmaceuticals Market by Country 2016 -2026 (USD Billion) 6.5.5.Middle East and Africa Biopharmaceuticals Market By Product 2016 -2026 (USD Billion) 6.5.6.Middle East and Africa Biopharmaceuticals Market By Application 2016 -2026 (USD Billion) 7. Competitive Landscape Analysis 7.1. Global Biopharmaceuticals Market Company Revenue, (USD Billion), 2016-2019 7.2. Global Biopharmaceuticals Market Company Share, (%), 2016-2019 8. Global Biopharmaceuticals Market Price Analysis 8.1. Global Biopharmaceuticals Market Price By Regions 9. Global Biopharmaceuticals Market Value Chain Analysis 10. Company Profiles 10.1.

10.2.

10.3.

10.4.

10.5.

10.6.

10.7.

10.8.

10.9.

10.10.

Sanofi Pfizer Inc. Novo Nordisk A/S Merck & Co. Inc. Johnson & Johnson F. Hoffmann-La Roche Ltd. Eli Lilly and Company Biogen Inc. Abbott Laboratories Amgen Inc. Others

11. Appendix 12. List of Tables 13. List of Figures

9

Transilience Market Research | Sales@transiliencemarketresearch.com

Declaimer

In response to request/orders received, Transilience Analytics provides strategic business/market analysis services to a select group of customers that are limited to publications containing valuable market information. The publication is solely for our customers’ internal use. It is acknowledged by our customer, by placing the order that no part of this strategic market analysis service is for general publication or disclosure to third party.

Transilience Analytics doesn’t make any warranty for the accuracy of the data as these are primarily based on interviews and therefore, liable for fluctuation. Also, Transilience Analytics doesn’t take responsibility for incorrect information supplied by manufacturers or users.

Any resale, lending, disclosure or reproduction of this publication can only be made with prior written permission from Transilience Analytics. Transmission and/or reproduction of this document by any means or in any form (includes photocopying, mechanical, electronic, recording or otherwise) are prohibited without the permission of Transilience Analytics.

10

Transilience Market Research | Sales@transiliencemarketresearch.com

About Transilience Market Research

Transilience Market Research is a one stop industry provider of actionable and timely intelligence.

We publish exclusive market research reports for more than 10 industry verticals. Since our inception our mission is to deliver cost effective reliable resources to back clients in decision-making processes and business development strategies. Providing B2B research to Fortune 500 companies and consulting research services. We are committed to deliver sustainable, profitable growth through in depth market research solutions.

Contact: +91-9404545879|Email us at sales@transiliencemarketresearch.com

Follow us on:

11

Transilience Market Research | Sales@transiliencemarketresearch.com